Today, the National Highway Traffic Safety Administration (NHTSA), the State Attorneys General and Consumer Protection Agencies and the Ad Council joined with Twentieth Century Fox Television and Twentieth Century Fox Home Entertainment to unveil new public service advertisements (PSAs) featuring scenes from season three of Fox’s award-winning television series “Glee” to educate young adult drivers (16-24) of the dangers of texting while driving.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57432-ad-council-nhtsa-and-glee-encourage-young-adults-to-not-text-and-drive
In preparation for July 4th and the summer months when instances of food poisoning increase, the Ad Council and the U.S. Department of Agriculture’s Food Safety and Inspection Service, in partnership with the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), are continuing their national Food Safe Families public service campaign, the first multimedia effort designed to raise awareness of the risks of foodborne illness (or food poisoning) in the home.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56338-ad-council-usda-hhs-food-safe-families-public-service-campaign
Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta’s revolutionary new Agility™* MLC promises a new level of precision and delivery speed in radiation therapy treatments for cancer patients. Elekta recently received 510(k) clearance (K121328) from the U.S. Food and Drug Administration (FDA) for Agility, enabling U.S. medical centers to provide these clinical benefits to their patients with cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55638-elekta-agility-radiation-therapy-radiotherapy-cancer-sbrt
U.S. Transportation Secretary Ray LaHood today joined National Highway Traffic Safety Administrator David Strickland and Safe Kids President and CEO Kate Carr for the kick-off of Child Passenger Safety Week to remind parents and caregivers to make sure that they are properly using and installing their child safety seats. A new National Highway Traffic Safety Administration (NHTSA) survey shows that parents are making five significant mistakes when using car seats and booster seats. It also found that one in five parents do not read any instructions when installing seats.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57925-nhtsa-child-passenger-safety-week-2012
In a revolutionary treatment for early-onset scoliosis (EOS), a team of surgeons implanted adjustable growing rods in two children from California. The pioneering surgeries — the first ever in the United States — were performed on May 7th at Rady Children’s Hospital in San Diego. The Food and Drug Administration (FDA) granted Compassionate Use approval to use the MAGEC™ (MAGnetic Expansion Control) System, developed by Ellipse Technologies, Inc., for these two patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61604-rady-children-s-hospital-san-diego-ellipse-magec-early-onset-scoliosis-eos
Inspired by its surrounding southwestern landscape, the Health Sciences Education Building (HSEB) at The University of Arizona College of Medicine-Phoenix is one of the most innovative construction projects in the United States utilizing predominately recycled copper. Using nearly 6,000 copper panels and more than 10,000 copper parts, this 268,000 square-foot building consists of six stories of administration and faculty offices, lecture halls, learning studios, flexible classrooms, clinical suites, gross anatomy facilities, laboratories and conference rooms.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61608-copper-development-green-sustainability-video-case-study-credit-architects
Money Management International (MMI) is participating in a nationwide partnership to help families struggling with their mortgage payments apply for help from the Federal government’s Making Home Affordable Program (MHA). The MHA program is an important part of the Obama administration’s comprehensive plan to help homeowners get mortgage relief and avoid foreclosure.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52440-money-management-international-mmi-mortgage-relief-mha-program
To promote the adoption of teenagers from foster care, the Administration for Children and Families (ACF), AdoptUSKids and the Ad Council are unveiling a new series of multimedia public service advertisements (PSAs). Today, more than 33,000 teenagers await adoption from the U.S. foster care system. Nearly 50 percent (14,000) are between the ages of 14 and 16.
These new PSAs are part of the Adoption from Foster Care campaign launched in 2004. Since the launch of the campaign more than 15,000 children have been placed with a permanent family.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58394-ad-council-adoption-psas-raise-awareness-of-teenagers-in-us-foster-care
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
Modern semitrailers for the most part do a good job of keeping passenger vehicles from sliding underneath them, greatly increasing the chances of surviving a crash into the back of a large truck, recent tests by the Insurance Institute for Highway Safety (IIHS) show. But in crashes involving only a small portion of the truck’s rear, most trailers fail to prevent potentially deadly underride.
Earlier research showed that the minimum strength and dimensions required for underride guards are inadequate, prompting the Institute to petition the National Highway Traffic Safety Administration (NHTSA) in 2011 for tougher standards. The Institute also asked the agency to consider applying the standards to other types of large trucks, such as dump trucks that aren’t required to have any underride guards.
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
